Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Top 4%
20.5Top 4%
Open Access
11469 citations · base score 9.3
datarank_citation_only_1hop_v4Methodology
›Data sources & pipeline
Pipeline:CrossRefSciBERTdoi-metadataOpenAlexDataRank
Enrichment:Pending
FAIR ChecklistContext only (not used in score)
FFindable
Has DOI
AAccessible
Open Access
IInteroperable
RReusable
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
DataRank Breakdown
Base Component 7%Network Component 93%
Base Score Contribution
1.4
From this paper's citation signal
Citation Network Contribution
19.1
From 177 citing papers with measurable signal